Recombinant KLK1: the next step in stroke and preeclampsia treatment
With its lead candidate DM199, DiaMedica Therapeutics is advancing a recombinant form of KLK1 to res...
29 Business Park Dr.,
Branford,
CT 06405
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s suite of technologies is powered by a first-of-its-kind sequencing chip designed to enable next-generation protein sequencing™ and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing.
With its lead candidate DM199, DiaMedica Therapeutics is advancing a recombinant form of KLK1 to res...
New research has discovered a key survival mechanism in metastatic melanoma, revealing that cancer c...
Researchers have discovered that pancreatic tumours evade the immune system by disguising themselves...
Unlock Exclusive Industry Insights